The ELRIG Drug Discovery 2014 programme will contain presentations from leading scientists across Europe and beyond, covering exciting advances in basic and translational aspects of drug discovery. The scientific sessions will include Innovations in Assay Development, Oncology Drug Discovery, Target Validation and Engineered Proteins for Therapy.
We will be showcasing the next generation SpectraMax® MiniMax™ 300 imaging cytometer enabling both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax® i3 Multi-Mode Microplate Reader. Also on show, enabling both ELISAs and western blot on one plate reader, the new ScanLater™ Western Blot Detection System is the first western blot application for a microplate reader.
We will also be demonstrating the ImageXpress® Micro XLS System; a widefield high content microscope capable of providing automated cellular imaging in fluorescent, transmitted light, and phase-contrast modes for fixed- or live-cell assays. Flexibility, speed and quality are assured with 3X field-of-view, industry-leading stage and autofocus control, a broad range of research-grade objective lenses, multiple filter options, and a gallery of MetaXpress®Software solutions to optimize and speed up image analysis. A modular system design enables instrument enhancements for assays ranging from simple label-free imaging to long-term monitoring of cellular responses, compound addition and post-wash recovery. Individual cells can be tracked during multi-day time-lapse experiments.